ARCHIVES

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Letter From Congress Prompts NCI To Pull Abortion Fact Sheet From Web

July 12, 2002

French Cancer Group Vow to Spend More On Cancer Research

January 12, 1996

In Brief: Robert Miller To Head International Affairs Office’ Pitot: No Basis for 20% Estimate

December 1, 1978

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

In Brief: CDP Awarded Contract To Do Facilities Survey; MIHICH Appointment Official; Kraybill Retires

August 24, 1984

Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials

March 14, 1980